Australian Pharmaceutical Industries Ltd
ASX:API

Watchlist Manager
Australian Pharmaceutical Industries Ltd Logo
Australian Pharmaceutical Industries Ltd
ASX:API
Watchlist
Price: 1.53 AUD Market Closed
Market Cap: AU$753.8m

P/B

1.7
Current
No historical data
Comparison unavailable

Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.

P/B
1.7
=
Market Cap
AU$753.8m
/
Total Equity
AU$438.8m

Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.

P/B
1.7
=
Market Cap
AU$753.8m
/
Total Equity
AU$438.8m

Valuation Scenarios

Australian Pharmaceutical Industries Ltd is trading above its 3-year average

If P/B returns to its 3-Year Average (1.7), the stock would be worth AU$1.53 (0% downside from current price).

Statistics
Positive Scenarios
2/4
Maximum Downside
0%
Maximum Upside
+90%
Average Upside
36%
Scenario P/B Value Implied Price Upside/Downside
Current Multiple 1.7 AU$1.53
0%
3-Year Average 1.7 AU$1.53
0%
5-Year Average 1.7 AU$1.53
0%
Industry Average 3.3 AU$2.9
+90%
Country Average 2.7 AU$2.38
+56%

Forward P/B
Today’s price vs future total equity

Not enough data available to calculate forward P/B

Peer Comparison

All Multiples
P/B
P/E
All Countries
Close

Market Distribution

In line with most companies in Australia
Percentile
32nd
Based on 2 062 companies
32nd percentile
1.7
Low
0 — 1.6
Typical Range
1.6 — 4.3
High
4.3 —
Distribution Statistics
Australia
Min 0
30th Percentile 1.6
Median 2.7
70th Percentile 4.3
Max 2 199.4

Australian Pharmaceutical Industries Ltd
Glance View

Market Cap
753.8m AUD
Industry
Health Care

Australian Pharmaceutical Industries Ltd. engages in the wholesale, product delivery, retail services, marketing programs and business advisory services. The company is headquartered in Melbourne, Victoria. The Company’s segments include Australia and New Zealand. The Australia segment is engaged in distribution of pharmaceutical, medical, health, beauty and lifestyle products and retail services to pharmacies, the purchase and sale of health, beauty and lifestyle products and services within the retail industry, including cosmetic products and non-invasive procedures. The New Zealand segment manufactures and owns rights for pharmaceutical medicines and consumer toiletries. The firm's brands include Priceline & Priceline Pharmacy, which is a health, beauty and wellbeing retailer; Soul Pattinson Chemist, which is a pharmacy brand; Pharmacist Advice, which offers professional service and advice; Club Premium, which is a club for independent pharmacies, and Pharmacy Best Buys, which offers a catalog program.

API Intrinsic Value
Not Available
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett